Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)

Summary

Patients are randomized into 2 groups (A and B), subsequently group A is subjected to a cycle of 6 weekly injections of 3 ml of autologous PRP while group B is subjected to 6 weekly injections of 1 ml of caverject (alprostadil) 20 mcg. After 4 (four) weeks the groups will be crossed, so group A will be subjected to 6 weekly injections of 1 ml of caverject (alprostadil) 20 mcg while group B will be subjected to a cycle of 6 weekly injections of 3 ml of autologous PRP.

Timeline

Start

2023-04-01

Primary completion

2024-11-01

Completion

2025-11-01

Drugs

Indications